ARTICLE | Company News
BioDelivery, Collegium deal
May 23, 2016 7:00 AM UTC
BioDelivery granted Collegium exclusive, U.S. rights to pain drug Onsolis fentanyl buccal soluble film. Collegium expects to launch the product in mid-2017. BioDelivery will receive $2.5 million up f...